Literature DB >> 8734834

Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States)

G Ursin1, M C Pike, S Preston-Martin, G d'Ablaing, R K Peters.   

Abstract

The incidence of adenocarcinoma of the cervix increased steadily in young women in the United States between the early 1970s and the mid-1980s. Despite this increase, little is known about the etiology of this cancer, although a role for risk factors for both squamous cell carcinoma of the cervix and endometrial adenocarcinoma has been suggested. Incident cases of adenocarcinoma of the cervix diagnosed in women born after 1935 (ages 42 to 56 at diagnosis) were identified from the Los Angeles (California) County Cancer Surveillance Program (LACCSP). Data from personal interviews with 195 cases and 386 controls (matched on age, race, and neighborhood) were analyzed. Compared with women in the highest categories of education and income, women in the lowest categories had a 2.5 and 3.1-fold elevated risk of adenocarcinoma of the cervix. Number of sexual partners, especially before age 20, was strongly predictive of risk (odds ratio = 5.6, 95 percent confidence interval = 1.4-22.0 for 10 or more compared with no partners before age 20). Smoking was not associated significantly with risk. Weight gain and long-term use of oral contraceptives increased risk, while long-term diaphragm use was protective. This study suggests that both sexual and hormonal factors are important etiologic factors for adenocarcinoma of the cervix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734834     DOI: 10.1007/bf00052946

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  30 in total

1.  Assessment of risk patterns in cancer of the cervix: a comparison between greater Bombay and western countries.

Authors:  D J Jussawalla; V A Deshpande; S J Standfast
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

2.  Cervical adenocarcinoma and oral contraceptives.

Authors:  C Chilvers; D Mant; M C Pike
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05

Review 3.  Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem.

Authors:  S K Kjaer; L A Brinton
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  Oral contraceptive use and adenocarcinoma of cervix.

Authors:  G Ursin; R K Peters; B E Henderson; G d'Ablaing; K R Monroe; M C Pike
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

5.  Cancer of the uterine cervix in Norway by histologic type, 1970-84.

Authors:  T J Eide
Journal:  J Natl Cancer Inst       Date:  1987-08       Impact factor: 13.506

6.  The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis.

Authors:  M A Duggan; S E McGregor; J L Benoit; M Inoue; J G Nation; G C Stuart
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

7.  Cigarette smoking and the risk of endometrial cancer.

Authors:  L A Brinton; R J Barrett; M L Berman; R Mortel; L B Twiggs; G D Wilbanks
Journal:  Am J Epidemiol       Date:  1993-02-01       Impact factor: 4.897

8.  Reproductive factors and risk of cancer of the uterine corpus: a prospective study.

Authors:  G Kvåle; I Heuch; G Ursin
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

9.  Parity as a risk factor for cervical cancer.

Authors:  L A Brinton; W C Reeves; M M Brenes; R Herrero; R C de Britton; E Gaitan; F Tenorio; M Garcia; W E Rawls
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

10.  The epidemiology of endometrial cancer in young women.

Authors:  B E Henderson; J T Casagrande; M C Pike; T Mack; I Rosario; A Duke
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

View more
  9 in total

1.  Metabolic components and recurrence in early-stage cervical cancer.

Authors:  Hee Kyung Ahn; Jin Woo Shin; Hong Yup Ahn; Chan-Yong Park; Nak Woo Lee; Jae Kwan Lee; In Cheol Hwang
Journal:  Tumour Biol       Date:  2014-11-15

2.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Cancer registries in epidemiologic research.

Authors:  H H Storm
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

Review 4.  The association of obesity and cervical cancer screening: a systematic review and meta-analysis.

Authors:  Nisa M Maruthur; Shari D Bolen; Frederick L Brancati; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

5.  Reproductive variables and risk of uterine cervical cancer in Norwegian registry data.

Authors:  T Bjørge; O Kravdal
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

6.  Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population.

Authors:  Eribeth K Penaranda; Navkiran Shokar; Melchor Ortiz
Journal:  ISRN Oncol       Date:  2013-01-21

7.  A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma.

Authors:  Peng Guo-Qing; Yang Yuan; Zhong Cai-Gao; Yin Hongling; Hu Gonghua; Tian Yan
Journal:  J Exp Clin Cancer Res       Date:  2010-09-17

8.  Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection.

Authors:  Xin Huang; Qun Zhao; Pingting Yang; Ying Li; Hong Yuan; Liuxin Wu; Zhiheng Chen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer.

Authors:  J Green; A Berrington de Gonzalez; S Sweetland; V Beral; C Chilvers; B Crossley; J Deacon; C Hermon; P Jha; D Mant; J Peto; M Pike; M P Vessey
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.